Vireo Growth (VREOF) Total Liabilities (2020 - 2026)
Vireo Growth's (VREOF) quarterly Total Liabilities came in at $634.7 million in Q1 2026, up 180.09% year-on-year from $226.6 million in Q1 2025, and up 24.5% quarter-over-quarter from $509.8 million in Q4 2025.
Vireo Growth (VREOF) Total Liabilities (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Total Liabilities across 7 years of filings, most recently posting $634.7 million for Q1 2026.
- Total Liabilities for Q1 2026 came in at $634.7 million, up 180.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $634.7 million (up 180.09% YoY), and the FY2025 annual result was $509.8 million, up 128.3% from the prior year.
- Total Liabilities came in at $634.7 million for Q1 2026 at Vireo Growth, up from $509.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $634.7 million in Q1 2026 to a low of $131.6 million in Q1 2022.
- The 5-year median for Total Liabilities is $204.9 million (2024), against an average of $256.5 million.
- Across the five-year window, Total Liabilities gained 6.16% in 2025 and soared 180.09% in 2026, its largest moves.
- Vireo Growth's Total Liabilities stood at $155.7 million in 2022, then gained by 27.99% to $199.3 million in 2023, then gained by 12.04% to $223.3 million in 2024, then jumped by 128.3% to $509.8 million in 2025, then gained by 24.5% to $634.7 million in 2026.
- The last three Total Liabilities figures came in at $634.7 million (Q1 2026), $509.8 million (Q4 2025), and $432.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 31.81 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 11.92 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 813.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 148.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.50 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.72 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.51 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.82 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.13 Bn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 634.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 634.70 Mn |
| Dec 31, 2025 | 509.80 Mn |
| Sep 30, 2025 | 432.61 Mn |
| Jun 30, 2025 | 390.76 Mn |
| Mar 31, 2025 | 226.61 Mn |
| Dec 31, 2024 | 223.30 Mn |
| Sep 30, 2024 | 204.87 Mn |
| Jun 30, 2024 | 217.24 Mn |
| Mar 31, 2024 | 213.46 Mn |
| Dec 31, 2023 | 199.31 Mn |
| Sep 30, 2023 | 184.52 Mn |
| Jun 30, 2023 | 173.88 Mn |
| Mar 31, 2023 | 160.70 Mn |
| Dec 31, 2022 | 155.72 Mn |
| Sep 30, 2022 | 156.85 Mn |
| Jun 30, 2022 | 144.83 Mn |
| Mar 31, 2022 | 131.65 Mn |
| Dec 31, 2021 | 123.96 Mn |
| Sep 30, 2021 | 113.25 Mn |
| Jun 30, 2021 | 56.43 Mn |